ADGM Stock - Adagio Medical Holdings, Inc.
Unlock GoAI Insights for ADGM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $269,000 | $300,000 | $189,000 | $270,000 | N/A |
| Gross Profit | $-1,668,000 | $-1,006,000 | $-686,000 | $-888,000 | N/A |
| Gross Margin | -620.1% | -335.3% | -363.0% | -328.9% | N/A |
| Operating Income | $-62,480,000 | $-27,942,000 | $-23,913,000 | $-20,645,000 | $-13,539 |
| Net Income | $-53,763,000 | $-38,146,000 | $-23,673,000 | $-19,938,000 | $-13,539 |
| Net Margin | -19986.2% | -12715.3% | -12525.4% | -7384.4% | N/A |
| EPS | $-3.54 | $-4.86 | $0.06 | $-0.34 | $-0.00 |
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 2nd 2025 | Lake Street | Initiation | Buy | $4 |
Earnings History & Surprises
ADGMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.43 | $-0.66 | -53.5% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | — | $-0.35 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.50 | — | — |
Latest News
Lake Street Initiates Coverage On Adagio Medical Holdings with Buy Rating, Announces Price Target of $4
📈 PositiveAdagio Medical Holdings Q3 EPS $(0.66) Down From $0.02 YoY
📉 NegativeAdagio Medical Raises $19M In Private Placement Of 9.79M Shares And Milestone Warrants Priced At $1.94 Each, With Potential Additional $31M From Warrant Exercises
📈 PositiveAdagio Medical falls as it prices up to $50M private placement
📉 NegativeAdagio Medical Prices $50M Of Securities
📈 PositiveAdagio Medical Presents Preliminary Acute Safety And Efficacy Data From FULCRUM-VT Study Of ULTC For SMVT In Cardiomyopathy Patients At 20th Annual VT Symposium
📈 PositiveAdagio Medical Completes Enrollment In FULCRUM-VT Clinical Trial Of Ultra-Low Temperature Cryoablation
📈 PositiveAdagio Medical Says Results From Its FULCRUM-VT U.S. Pivotal Study Will Be Presented At Late-Breaking Session At 0th Annual International Symposium on Ventricular Arrhythmias Oct. 10-11
➖ NeutralAdagio Medical Chief Business Officer Role Expanded To Include Chief Financial Officer Responsibilities
➖ NeutralAdagio Medical Posts Narrower Q2 Loss
📈 PositiveFrequently Asked Questions about ADGM
What is ADGM's current stock price?
What is the analyst price target for ADGM?
What sector is Adagio Medical Holdings, Inc. in?
What is ADGM's market cap?
Does ADGM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ADGM for comparison